|
Sale of Therapeutic Support Systems Assets (Details) (USD $)
|
0 Months Ended | 2 Months Ended | 3 Months Ended | 12 Months Ended | 10 Months Ended | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Nov. 08, 2012
|
Dec. 31, 2011
Successor [Member]
|
Dec. 31, 2013
Successor [Member]
|
Sep. 30, 2013
Successor [Member]
|
Jun. 30, 2013
Successor [Member]
|
Mar. 31, 2013
Successor [Member]
|
Dec. 31, 2012
Successor [Member]
|
Sep. 30, 2012
Successor [Member]
|
Jun. 30, 2012
Successor [Member]
|
Mar. 31, 2012
Successor [Member]
|
Dec. 31, 2013
Successor [Member]
|
Dec. 31, 2012
Successor [Member]
|
Nov. 03, 2011
Predecessor [Member]
|
|
| Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] | |||||||||||||
| Proceeds from Divestiture of Businesses | $ 241,500,000 | ||||||||||||
| Operating results of the TSS product portfolio included in discontinued operations | |||||||||||||
| Revenue | 42,492,000 | 0 | 188,121,000 | 214,710,000 | |||||||||
| Earnings (loss) before income taxes | 6,223,000 | (5,371,000) | 149,916,000 | 37,055,000 | |||||||||
| Income tax expense (benefit) | 2,396,000 | (2,068,000) | 57,718,000 | 4,954,000 | |||||||||
| Earnings (loss) from discontinued operations, net of tax | $ 3,827,000 | $ (1,004,000) | $ (255,000) | $ (628,000) | $ (1,416,000) | $ 95,878,000 | $ 2,032,000 | $ (32,000) | $ (5,680,000) | $ (3,303,000) | $ 92,198,000 | $ 32,101,000 | |